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A. SPECIFIC AIMS 
In recent years, the application of magnetic nanoparticles (MNPs) in magnetic fluid hyperthermia 
(MFH) has emerged as a viable alternative to radiotherapy, chemotherapy, and surgery for the 
treatment of a wide variety of cancerous tumors.  The MFH procedure, which requires raising the 
temperature of the tumor to 42 – 45o C, has become more prevalent in Europe and Asia as compared 
to the rest of the world.  Despite a number of ongoing phase III trials to use MHF clinically, it still 
remains a mostly experimental method in the United States due to the possibility of necrosis of normal 
tissue due to overheating.  Therefore the search is on for a smart MNP system with the ability to 
maintain a temperature in the desired range without the possibility of overheating. 
The concept of MFH is based on the high heat-sensitivity of malignant neoplastic tissue when 
compared to that of normal human cells.  For local magnetic fluid hyperthermia, MNPs in a carrier fluid 
are delivered to the tumor site via direct injection or targeted to the site through the use of tumor 
specific antibodies.   Once inside the tumor, the nanoparticles are exposed to an alternating magnetic 
field which causes heating of the MNPs due to magnetic relaxation (both Néel and Brownian 
mechanisms) as well as hysteretic losses. Such a rise in temperature is enough to kill cancer cells while 
leaving healthy tissue unharmed. 
Much research into MFH has centered on iron-oxide-based based materials due to their 
ferrimagnetic nature and biocompatibility; however, one desirable property which these materials lack 
is the ability to “self-control” the thermal characteristics of the hyperthermia treatment.  During 
treatment, heat conduction and energy absorption are extremely difficult to monitor in vivo which may 
cause overheating that can damage normal human tissue.  In some complex magnetic oxides the “turn-
off” temperature for the ferrimagnetic behavior (referred to as the Curie temperature) can be 
suppressed to coincide with the desired maximum MFH temperature. These smart materials, such as 
La1-xSrxMnO3, are the subject of our proposed investigation.  
 Specific Aim #1:  Synthesis of La1-xSrxMnO3 for use in MFH studies.  We will prepare a series of 
samples by varying x between 0.1 and 0.8 in La1-xSrxMnO3 to obtain materials with different Curie 
temperatures in the range of 40˚C – 50˚C.  This will provide MNPs to regulate the maximum 
temperature reached during MFH treatments. 
 Specific Aim #2:  Investigation of the structural characteristics of the synthesized samples.  
The La1-xSrxMnO3 MNPs will be characterized by X-ray diffraction (XRD), scanning electron microscopy 
(SEM) and transmission electron microscopy (TEM) for phase identification as well as the 
determination of particle morphology.  
 Specific Aim #3:  Investigation of the magnetic properties of the proposed nanoparticles 
through the use of dc- and ac-magnetometry.  In order to determine the Curie temperature and 
magnetodynamics of the La1-xSrxMnO3 MNPs we will perform temperature-dependent magnetic 
experiments using the magnetometer at Wayne State University.  
 Specific Aim #4:  Investigation of the magnetic heating of an aqueous suspension of the 
nanoparticles under an alternating magnetic field.  These studies must be performed for a number of 
reasons which include the determination of the temperature dependent specific absorption rate (SAR) 
of the aqueous La1-xSrxMnO3 MNP solution as well as the “shut-off” characteristics of the smart MNPs 
as they near their Curie temperature. 
B. BACKGROUND AND SIGNIFICANCE 
 Magnetic hyperthermia has been widely considered as a possible non-invasive treatment for 
cancerous solid tumors since its introduction in 1957 when Gilchrist et al [1] used 20—100 nm 
particles of γ-Fe2O3 in conjunction with an alternation magnetic field in the MHz range to heat 
various tissue samples.  In broad terms, MFH involves the dispersion of magnetic nanoparticles 
throughout a tumor site and the exposure of these nanoparticles to a small (~mT) time-varying 
magnetic field in the RF range.  The relaxation of the magnetic nanoparticles into the field causes 
dispersion of heat due to various methods of energy loss (Néel relaxation, Brownian relaxation, 
hysteretic losses, etc.).  This heat is conducted to the nearby cancerous tissue whereby, if the 
temperature can be maintained above 
a threshold of 42˚C – 46˚C for a time of 
not less than 30 minutes, the cancer 
will be destroyed via necrosis, 
coagulation and carbonization.  The 
most commonly used materials for this 
treatment are mono-metallic oxides 
such as γ-Fe2O3 and Fe3O4 (Figure 1) 
because of their abundance and 
biocompatibility.   
In general, heat production via 
magnetic materials in alternating 
magnetic fields arises due to two 
general classes of materials:  multi-
domain ferro(ferri-)magnetic systems 
and single-domain superparamagnetic 
systems.  In the former, heat 
production originates primarily through hysteretic power losses.  For superparamagnetic 
nanoparticles, heating is accomplished through losses as the particles’ superspins align with the 
external field through the Néel mechanism (rotation of the magnetic moment within a fixed 
particle) and Brownian motion (physical rotation of the particle with a fixed moment), the latter of 
which can contribute to the dissipation of energy by means of friction [2].  Typically, MFH is 
accomplished using superparamagnetic iron oxide nanoparticles (Fe3O4 and γ-Fe2O3) [3-7].  
However, these materials lack the ability to self-control the maximum temperature reached by 
MFH due to their high Curie temperatures.  Perovskite manganites have been proposed as possible 
materials in which the Curie temperature can be suppressed into the range between 42—38˚C by 
doping with non-magnetic cations.  These materials, of the form La1-xSrxMnO3 and La1-xAgxMnO3 [8-
9], have been shown to have Curie temperatures in this desired range (achieved through the 
replacement of lanthanum by strontium or silver ions in the perovskite A sites).  We wish to study 
these materials in order to confirm the optimized doping needed in order to achieve a Curie 
temperature near 46˚C. 
C. SUMMARY OF EXPERIMENTAL DESIGN AND METHODS 
Synthesis of perovskite manganite nanoparticles.  The synthesis of La1-xSrxMnO3 nanoparticles 
will be accomplished via solid state reaction of La2O3, SrCO3 and MnO3 powders mixed in 
appropriate stoichiometric quantities, pressed into pellets and heated to high temperatures (up to 
1500˚C).  The resulting powders will be milled until we have achieved the desired particle size (20—
100 nm diameters).  A variety of different stoichiometric samples will be made in order to compare 
the physical properties of each sample (we will vary the amount of strontium in the samples). 
Structural and morphological characterization.  Samples synthesized via the method above will 
be analyzed through x-ray diffraction in order to confirm the perovskite nature of the materials in 
addition to confirmation of particle size.  In addition, scanning and transmission electron 
microscopy will be used to further investigate the phase and morphology of the samples. 
Magnetic characterization.  Using a Quantum Design Model 6000 Physical Properties 
Measurement system (at Wayne State University), we will investigate the ac- and dc- magnetic 
properties of the synthesized samples.  We will specifically look at the temperature-dependent 
properties in order to determine the Curie temperature of the samples. 
Analysis of the heating characteristics.  The heating characteristics of each sample will be 
measured using Kettering University’s Ambrell EASYHEAT system.  Specifically, we are interested in 
determining two main points:  The specific absorption rate (SAR) of the sample as it heats from 
room temperature, and the samples ability to hold a constant temperature in the range of 42—
46˚C while constantly being driven by the ac magnetic field.  The SAR is defined to be the power 
dissipated by a magnetic material subjected to an alternating magnetic field.  For MFH, the SAR is 
related to the specific heat of the solvent in which the magnetic nanoparticles are suspended, the 
weight fraction of the magnetic element, and the slope of the temperature vs. time curve. 
D. POTENTIAL SOURCES OF EXTERNAL FUNDING 
The preliminary data obtained from this project presents itself well to solicitation of funds from 
both the National Institutes of Health (NIH) and the National Science Foundation (NSF).  For 
example, the Biomaterials program (BMAT) within the NSF’s Division of Materials Research (DMR) 
which supports fundamental research related to (1) biological materials, (2) biometric, bioinspired, 
and bioenabled materials, (3) synthetic materials intended for applications in contact with 
biological systems, and (4) the processes through which nature produces biological materials (taken 
from www.nsf.gov) would be ideal sources of future external funding for this research. 
 
 
 
 
 
E. BUDGET 
We anticipate the following expenses for this project 
Budgeted Item Amount 
Undergraduate Research Assistantships $3,000.00 
Planetary Ball Mill (cost-share with startup funds – IGA 350134) $1,500.00 
Materials and Lab Supplies $1,000.00 
Publication Charges $500.00 
TOTAL $6,000.00 
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